Budesonide Inhalation Suspension
Product Images NDC 68180-984

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68180-984). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 01)

Chemical structure diagram depicting the molecular structure of budesonide, the active ingredient in budesonide inhalation suspension by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 02)

Line graph titled 'Nighttime Asthma Change from Baseline' depicting mean change from baseline nighttime asthma symptoms over a 12-week period. The x-axis shows time intervals from baseline to weeks 0-12, and the y-axis shows mean change values from 0 to -0.6. Four lines represent treatment groups: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily, with treatment groups showing greater symptom reduction than placebo. P-values indicating statistical significance are provided for each active dose.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 03)

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean changes in nighttime asthma symptoms over 12 weeks for three groups: Placebo, 0.25 mg dose twice daily, and 0.5 mg dose twice daily. The graph plots data points from baseline through several biweekly intervals, with placebo showing little improvement and both drug doses showing reductions in symptoms. P-values for 0.25 mg and 0.5 mg doses are 0.022 and 0.021, respectively.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 04)

A line graph titled "Nighttime Asthma Change from Baseline" showing mean change from baseline in nighttime asthma symptoms over weeks 0 to 12. Five lines represent different dosages: placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily, with symptom changes decreasing over time, indicating varying effectiveness. P-values for each dosage group versus placebo are included below the graph.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 05)

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 06)

An instructional black-and-white line drawing showing hands opening a blister pack containing individual doses, illustrating how to separate or remove a single unit from the strip. The image relates to budesonide inhalation suspension usage instructions.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 07)

An instructional illustration showing a hand holding a small vial, with arrows indicating a twisting motion to open the vial. This likely demonstrates how to activate or prepare a budesonide inhalation suspension dose for use.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 08)

Instructional illustration showing a hand holding a small vial or ampule of budesonide inhalation suspension, with an arrow indicating a twisting motion to open the vial for administration.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 09)

An instructional line drawing showing hands preparing a respiratory suspension inhaler device by inserting or adjusting a component into the inhaler canister, demonstrating proper handling technique for use.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 10)

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 11)

Label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Lupin Pharmaceuticals, Inc. The respiratory inhalation suspension is packaged as 5 single-dose ampules per pouch. The label includes usage instructions, storage conditions, and regulatory information along with barcodes and the NDC 68180-984-05.*

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 12)

Box label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Lupin Pharmaceuticals, Inc. The packaging includes instructions for use, emphasizing storage upright and use with a nebulizer. It is labeled for respiratory inhalation use, prescription only (Rx only), with a package containing 30 single-dose ampuls. The label includes barcodes and NDC 68180-984-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.